The Lab Rat's Final Report from the coal face
I had my cystoscopy this morning and all good and the Urologist said she could see clear signs of the old infection despite this occurring on 1 June, 2 months ago that lead to the bleeding.
Cytology was also good, as were blood tests, renal ultrasound, bowel screening test and 2 x prostate checks. No further sign of haematuria has occurred since 1 June so its now crystal clear it was just a bad bladder infection and I'm all good :) In the circumstances as its clear what the cause of the original haematuria was there is no point taking a CX bladder test.
I did have an interesting discussion with the Urologist about CX Bladder that might interest you guys.
After talking with a number of medical professionals about this process it was a relief to finally talk to someone who had an in-depth understanding of the benefits of it and it helped break the ice and keep my mind off what is a relatively unpleasant procedure, (cystoscopy).
My Urologist was involved in the original 100 person trial done by the Waitemata DHB and was very impressed with the CX Bladder test and its results and she added that they were very pleasant people to work with.
She went on to explain that its an issue of bulk funding. It costs them about $1,000 to do a cystoscopy but their costs don't go down if they also order up a CX Bladder test and at present from what she told me it isn't funded by the Government.
She went on to explain that whilst my procedure showed clear signs of the original cause of the haematuria if they had any doubts they would send me for a CT scan as the next procedure.
I asked her whether she thought it would take off in N.Z. ? Not unless its publically funded but she thought the prospects in the U.S. were better but results would take time to eventuate.
How much time and does that make the company worth its market capitalisation today...who would know ?
1.4 million views on this thread and over 10,000 posts says one thing to me...plenty of people looking for answers.
My closing thoughts from the coal face are this. The medical field is very, very slow to change. My Urologist told me a cystoscopy is the GOLD standard and that won't change anytime soon.
She went on to say if the day comes when its publically funded here and they can say with a 98% probability that a CX Bladder test replaces a Cystoscopy then they would encourage patients to use it instead of the other in a certain age group provided they accepted the risks, (I gathered a waiver would be required).
Its a good product, how much time it takes to get commercial traction and whether that's fairly reflected in the current market cap, who would really know ?
I think the stock is "highly speculative". It doesn't fit my investment profile but that's not to say it isn't worth a small punt within a well diversified investment portfolio. Good luck to all holders.
Yours faithfully
Lab Rat.